Mary Mckensie Murphy, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 328 Linden Ave, Wilmette, IL 60091 Phone: 847-475-1224 Fax: 847-475-0150 |
Rachel Loth, CNM, WHNP Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 328 Linden Ave, Wilmette, IL 60091 Phone: 847-475-1224 |
Ms. Josephine Claire Nowak, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 328 Linden Ave, Wilmette, IL 60091 Phone: 847-475-1224 |
Amanda Yeager, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 220 Charles Pl, Wilmette, IL 60091 Phone: 312-245-0653 |
News Archive
One of the greatest joys for parents is the birth of their child - and one of the greatest tragedies is the loss of that child. Now, Yale physician scientist Harvey J. Kliman, M.D., has developed an iPhone app that helps women contribute to research that aims to decrease the chance of pregnancy loss due to an undersized placenta, the fetal organ that provides nourishment to the fetus.
On 8 November, the World Health Organization (WHO) announced a shortfall of artemether + lumefantrine, an artemisinin-based combination therapy (ACT) used to treat malaria, for the period between November 2004 and March 2005
"Children in a refugee camp in South Sudan are dying at more than twice the rate internationally recognized as an emergency, according to new figures released by Medecins Sans Frontieres (MSF)," the Guardian reports.
The Contraceptive Pill celebrated its 50th birthday on Mother's Day this year. The Pill was approved by the FDA in 1960 giving greater control to women about when they would like to give birth. The choice was supposed to help eliminate unwanted pregnancies and help couples grow closer. It was also supposed to help the couple financially by not placing burdens of early children on them.
ABIVAX an innovative biotechnology company targeting the immune system to eliminate viral disease, announced today that the Company presented new preclinical data on ABX464, ABIVAX's first-in-class drug candidate for a functional cure of patients with HIV/AIDS, during this week's HIV DART scientific conference in Los Cabos, Mexico.
› Verified 5 days ago